Sunday, January 10, 2010

OTCMarketBulls Featured Company PLBI News: Proton Laboratories, Inc. Announces the Acquisition of Regenobody S.A.

Proton Laboratories Inc., (PLBI.PK), a biotechnology company that develops GREEN solutions utilizing electrolyzed water for both residential and commercial applications

Based in California, Proton Laboratories is a GREEN biotechnology company that develops new practical applications for electrolyzed water. The company alters the properties of water via electrolysis with electrolyte separation. Based upon proven technology, science, engineering, product design, and products that have been successfully developed over the past decade.

Proton Laboratories, Inc. Announces the Acquisition of Regenobody S.A.

SOSUA BAY, Dominican Republic, Jan 8, 2010 (GlobeNewswire via COMTEX) -- Proton Laboratories, Inc. (Pink Sheets:PLBI), a Washington corporation, today announced the acquisition of Regenobody S.A., a Dominican Republic company involved in some of the latest technologies associated with stem cell regeneration using the patient's own stem cells. Pursuant to the Agreement, the Company (PLBI) will issue 300,000,000 of its common shares to the Regenobody shareholders, which will result in the shareholders of Regenobody acquiring shareholder control of Proton Laboratories, Inc.

Armando Casciati, newly elected President of Proton Laboratories, Inc. stated that the new company will aggressively work toward completing the development of its laboratory and acquisition of the balance of the needed equipment from its Korean licensor and patent holder, RNLBIO. It is anticipated that a name change and symbol change will occur in the next 90 days. The prior Proton directors have resigned concurrent with the acquisition. More information may be seen at the Company's website www.regenobody.com.

This news release was distributed by GlobeNewswire, www.globenewswire.com

SOURCE: Proton Laboratories, Inc.


regeno

REGENOBODY IS A WORLD LEADER IN STEM CELLS TREATMENTS

By applying the regenerative powers of stem cells, REGENOBODY AGE REVERSAL achieves the target of halting the ageing degenerative process , improving the quality of life of people willing to maintain a young look and a real rejuvenation in the inside, with better functioning, re-energized and healthy organs.

REGENOBODY THERAPEUTIC brings the benefits of bioscience to patients who have been diagnosed with chronic debilitating diseases, offering viable, efficient therapeutic options.

Many different conditions can be successfully addressed using our special Stem Cell Therapies. Our institute utilizes the most potent cells in the world, today. Therapies are tailored for each individual, based upon their specific needs. Cells we use are obtained by the most modern technologic method. Our transplant physicians and stem cell laboratory scientists, have the most experienced and are regarded as the best in the world.

Stem cells derived from Autologous (Stem cells taken from your own body) and Allogeneic (Stem cells from a source other than your own) are used depending on the particular condition that needs to be treated.

You can rest assured that you will be receiving the most efficacious Stem cell transplant in one of the world's most modern and well equipped facilities.

Treatments are delivered by an experienced team of International and U.S. Board Certified Physicians who are guided by strict protocols ensuring excellence in medical care. Your journey toward new youth and wellness will begin with begins with the initial phone call and continues throughout treatment at one of our centers.

Proton Laboratories, Inc. Announces the Acquisition of Regenobody S.A. GlobeNewswire(Fri 2:25pm)
Proton Laboratories in Discussions for Chinese Distribution Marketwire(Tue, Apr 14)
Proton Laboratories Signs $18,500,000 Advertising Deal Marketwire(Fri, Feb 27)
Proton Labs Introduces HYDRANT H2O at NHRA Pomona Winternationals Marketwire(Mon, Feb 9)
Proton Labs to Begin Bottling Functional Water Marketwire(Fri, Feb 6)
Transparency - Sales - Revenue: Proton Laboratories Building on Years of Development Marketwire(Thu, Jan 22)

No comments: